mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.04 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.05 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.05 |